What is an Onko-Sure™ test?
Onko-Sure™ is a simple, non-invasive blood test, which targets a cancer-caused breakdown product. Onko-Sure™ detects a tumor marker that is associated with most cancers. The biological target for the Onko-Sure™ test is abundant and floats-freely in blood (unlike Carcinoembryonic antigen, CEA). Biomarker levels rise dramatically with cancer progression (up to 38 times greater than in normal patients). Onko-Sure™ may become the first “pan tumor” marker in general widespread usage. Onko-Sure™ has international regulatory approvals as a general cancer marker in Taiwan, South Korea, Vietnam, India and Europe (CE Mark certification). In addition, Onko-Sure™ is approved for the detection and monitoring of lung cancer in Canada (Health Canada). In the US, Onko-Sure™ has been cleared to market as a colorectal cancer monitoring test. ADI plans to apply for additional claims in the US and internationally.
